Carregant...
Patient-derived tumour xenografts for breast cancer drug discovery
Despite remarkable advances in our understanding of the drivers of human malignancies, new targeted therapies often fail to show sufficient efficacy in clinical trials. Indeed, the cost of bringing a new agent to market has risen substantially in the last several decades, in part fuelled by extensiv...
Guardat en:
| Publicat a: | Endocr Relat Cancer |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Bioscientifica Ltd
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118939/ https://ncbi.nlm.nih.gov/pubmed/27702751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-16-0251 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|